Company intelligence / Profile preview
Kite Pharma
Santa Monica, California, USAkitepharma.com ↗
- Ownership
- Public · GILD
- Employees
- ~1750
- Development stage
- Commercial
01
Overview
Kite’s lead products Yescarta® (axicabtagene ciloleucel) and Tecartus® (brexucabtagene autoleucel) are FDA-approved for relapsed/refractory large B-cell lymphoma and mantle cell lymphoma. Yescarta has demonstrated improved overall survival compared to standard care in DLBCL. The company continues to expand indications for its approved products and develop next-generation cell therapies with faster manufacturing times recently approved by the FDA
- Therapeutic areas
- OncologyHematology
- Modalities
- CAR T-cell therapies (Chimeric Antigen Receptor T-cell therapies)
- Industry
- Biotech
02
Drug pipeline
26 assets25 more assets in the full pipeline.
03
Partnerships
National Cancer Institute collaboration since 2012Appia Bio for allogeneic cell therapies research collaborationUniversity of Pennsylvania via the acquired rights from Tmunity Therapeutics deal
Beyond the preview
Go deeper on Kite Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kite Pharma.